Back

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study

30 August 2021 (07:15 - 07:24)
Organised by:
Congress Presentation Part of: Clinical questions: management of patients with atrial fibrillation Clinical ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

4 More presentations in this session

Presentation thumbnail
Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes
Assistant Professor Y. Kim (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Doctor M. Anjum (Baerum, NO)
Abstract Slides Video
Presentation thumbnail
Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Low incidence of major complications after the first six hours post-atrial fibrillation ablation - same-day discharge safe and feasible in most patients
Doctor A. Paul Nordin (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical questions: management of patients with atrial fibrillation

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 07:15 CET
You may be interested in
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources